ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,118.99
0.42%
Dow Jones
43,367.01
-0.10%
Gold vs US Dollar
2,670.48
0.68%
Brent Oil
73.555
0.98%
Bitcoin
96,905.54
2.69%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aclarion Inc (ACON)

  7. Aclarion Inc (ACON) News

Aclarion (ACON)

Aclarion Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACON
DateTimeSourceHeadlineSymbolCompany
21/11/202413:00GlobeNewswire Inc.Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM FlashNASDAQ:ACONAclarion Inc
10/10/202411:00GlobeNewswire Inc.Aclarion to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:ACONAclarion Inc
27/09/202410:57GlobeNewswire Inc.Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic ChangesNASDAQ:ACONAclarion Inc
13/09/202412:30GlobeNewswire Inc.PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI TechnologyNASDAQ:ACONAclarion Inc
12/09/202410:57GlobeNewswire Inc.Aclarion Provides Corporate Update on Nociscan AI Technology MilestonesNASDAQ:ACONAclarion Inc
10/09/202410:57GlobeNewswire Inc.Aclarion Announces Completion of First Nociscan Exams in LIFEHAB TrialNASDAQ:ACONAclarion Inc
06/09/202415:27GlobeNewswire Inc.Aclarion Added to PRISM Emerging Medical Devices IndexNASDAQ:ACONAclarion Inc
05/09/202410:57GlobeNewswire Inc.Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation MarketNASDAQ:ACONAclarion Inc
29/08/202420:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
29/08/202410:57GlobeNewswire Inc.Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New JerseyNASDAQ:ACONAclarion Inc
26/08/202420:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ACONAclarion Inc
23/08/202420:58Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
21/08/202411:57GlobeNewswire Inc.Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment PlansNASDAQ:ACONAclarion Inc
16/08/202420:56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
16/08/202420:01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ACONAclarion Inc
15/08/202413:48GlobeNewswire Inc.Aclarion to Present at August 20th Virtual Investor Summit Microcap EventNASDAQ:ACONAclarion Inc
14/08/202419:34Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACONAclarion Inc
14/08/202412:08GlobeNewswire Inc.Aclarion Announces First Commercial Agreement in MichiganNASDAQ:ACONAclarion Inc
13/08/202413:07GlobeNewswire Inc.Aclarion Hits Another Key Milestone by Adding Vitality - Third Major Payer to Cover Nociscan in Greater UKNASDAQ:ACONAclarion Inc
13/08/202413:05Edgar (US Regulatory)Form 253G3 -NASDAQ:ACONAclarion Inc
13/08/202411:56Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ACONAclarion Inc
12/08/202420:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
09/07/202411:00GlobeNewswire Inc.Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UKNASDAQ:ACONAclarion Inc
26/06/202412:30GlobeNewswire Inc.Aclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UKNASDAQ:ACONAclarion Inc
25/06/202412:30GlobeNewswire Inc.Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater LondonNASDAQ:ACONAclarion Inc
25/04/202413:14GlobeNewswire Inc.Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainNASDAQ:ACONAclarion Inc
06/03/202421:09Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACONAclarion Inc
04/03/202413:00GlobeNewswire Inc.Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar DiscsNASDAQ:ACONAclarion Inc
27/02/202420:22GlobeNewswire Inc.Aclarion Announces Closing of $3.0 Million Public OfferingNASDAQ:ACONAclarion Inc
27/02/202419:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONAclarion Inc
 Showing the most relevant articles for your search:NASDAQ:ACON

Your Recent History

LSE
0HJL
Autozone
AMEX
ARKA
ARK 21Shares Active Bitc...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06